A unique set of complex chromosomal abnormalities in an infant with myeloid leukemia associated with Down syndrome

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

(2016) D. A. Arber et al.   BLOOD

Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update

(2016) Neha Bhatnagar et al.   Current Hematologic Malignancy Reports

Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): Clinical and biological features and comparison with other acute myeloid leukemias with cytogenetic aberrations involving long arm of chromosome 3

(2015) Jose Maria Raya et al.   Hematology

Molecular Pathways: Mitogen-Activated Protein Kinase Pathway Mutations and Drug Resistance

(2013) A. L. Pritchard et al.   CLINICAL CANCER RESEARCH

Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study

(2013) M. Blink et al.   HAEMATOLOGICA

High frequency of copy number alterations in myeloid leukaemia of Down syndrome

(2012) Marjolein Blink et al.   BRITISH JOURNAL OF HAEMATOLOGY

Transient myeloproliferative disorder progression and acquired chromosomal abnormalities in children with Down syndrome

(2012) Verónica Judith Picos Cárdenas et al.   PEDIATRIC BLOOD & CANCER

Treatment and prognostic impact of transient leukemia in neonates with Down syndrome

(2008) J.-H. Klusmann et al.   BLOOD